Classifying collagen diseases using clinical and serological data, particularly antinuclear antibodies, shows promise for scleroderma and dermatomyositis. However, systemic lupus erythematosus and Sjögren's syndrome present challenges due to multiple antibodies and varied patient data.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: